BRAINAURORA-B

BrainAurora opened higher at 1.460 in the morning session, reached an intraday high of 1.525, then retreated to 1.490, up 2.76% from the previous close of 1.450, but still 91.62% below the 52-week high of 17.79 and below the 20-day MA of 1.526. The stock was lifted by a broad rally in brain-computer interface stocks, following recent announcements of published studies in top journals and joining the Beijing Frontier BCI Institute to accelerate clinical translation. However, the company continues to incur losses, with Q4 net loss of HKD 104.8 million, widening 134.69% YoY, while revenue grew 78% to HKD 66.7 million and net profit margin stood at -157.08%. The PB of 18.78x underscores the disconnect between weak fundamentals and speculative hype.

脑动极光今日上午盘中高开高走，涨幅约 5.3%，报 1.595 港元，主要受脑机接口板块情绪提振及公司近期多项合作进展带动。公司近期股价距 52 周高点 17.79 港元仍下跌超 91%，但较 52 周低点 1.41 港元已回升约 13%，日内振幅约 6%，盘中低开于 1.505 后震荡上行，成交量约 719 万股，换手率 0.53%。Q4 营收同比增 78% 至 6672 万港元，但净亏损扩大至 1.05 亿港元，ROE 降至-387%，基本面尚未改善。不过股价已站上 20 日均线 1.592 港元，短期技术面略有修复。

BrainAurora-B staged a sharp rally in the afternoon session, closing up about 5.7% at HKD 1.590, primarily driven by a broad brain-computer interface sector rally. The company has seen a series of positive catalysts, including the chairman's plan to purchase up to HKD 80 million in shares, a partnership with Tokyo Lifestyle for an AI health platform, and China's first commercial approval of a BCI product, all of which have sustained investor interest. However, the stock remains deeply beaten down, with a YTD decline of 76.6%, a price far below its 52-week high of HKD 17.79, and also below both the MA20 (HKD 1.617) and MA60 (HKD 2.121), indicating that while the rebound is strong, technical repair is still needed. Financially, Q4 2025 revenue grew 78.1% YoY to HKD 66.72 million, but net loss widened to HKD 104.8 million, with an EPS of -HKD 0.0888, suggesting that a fundamental turnaround is not yet in sight.

BrainAurora-B opened lower and declined steadily during the morning session, closing at HKD 1.475, a 5.14% drop from the previous close of HKD 1.555, with an intraday range of 5.95%. The decline was driven by fading hype around brain-computer interface concepts and deteriorating fundamentals. While Q4 2025 operating revenue rose 78.11% YoY to HKD 66.72 million, net loss widened to HKD 104.81 million, increasing 134.69% YoY, with EPS of -HKD 0.0888 and a net margin of -157.08%. The stock trades near its 52-week low of HKD 1.41, only 4.61% above it, and significantly below the 20-day MA of HKD 1.633 and 60-day MA of HKD 2.193, with a YTD decline of 78.31%. However, the stock has previously seen single-day gains of 8%-15% on BCI-related news, indicating short-term sensitivity to thematic catalysts.

BrainAurora opened at 1.515 in the morning session, surged to an intraday high of 1.560, then retreated to close at 1.545, up 3.34% from the previous close of 1.495, driven by a rally in brain-computer interface stocks. Recent catalysts include the chairman's plan to purchase up to HKD 80 million in shares and China's first commercial approval of a BCI product. Q4 2025 revenue jumped 78.11% YoY to HKD 66.72 million, but net loss widened 134.69% to HKD 104.8 million, with losses not narrowing despite revenue growth. At 1.545, the stock is 91.32% below its 52-week high of 17.79 and trades below both MA20 (1.648) and MA60 (2.232), indicating a still-depressed price level. However, today's volume of 7.86 million shares was lower than prior rally days, suggesting fading momentum.